Filing Details
- Accession Number:
- 0001567619-20-005413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-03 14:49:51
- Reporting Period:
- 2020-02-28
- Accepted Time:
- 2020-03-03 14:49:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1444380 | Nevro Corp | NVRO | Surgical & Medical Instruments & Apparatus (3841) | 562568057 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669489 | Patrick Schmitz | C/O Nevro Corp. 1800 Bridge Parkway Redwood City CA 94065 | Vice President, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-28 | 19,583 | $57.89 | 38,241 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-28 | 10,833 | $87.62 | 49,074 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-28 | 7,312 | $76.81 | 56,386 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-28 | 5,156 | $42.30 | 61,542 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-28 | 4,604 | $126.47 | 56,938 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-28 | 7,404 | $127.06 | 49,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-28 | 2,758 | $128.25 | 46,776 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-28 | 17,205 | $129.34 | 29,571 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-28 | 10,313 | $130.13 | 19,258 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-28 | 600 | $130.83 | 18,658 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-28 | 19,583 | $0.00 | 19,583 | $57.89 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-28 | 10,833 | $0.00 | 10,833 | $87.62 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-28 | 7,312 | $0.00 | 7,312 | $76.81 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-28 | 5,156 | $0.00 | 5,156 | $42.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 417 | 2026-03-13 | No | 4 | M | Direct | |
| 2,500 | 2026-11-15 | No | 4 | M | Direct | |
| 5,688 | 2027-11-13 | No | 4 | M | Direct | |
| 11,344 | 2028-11-26 | No | 4 | M | Direct |
Footnotes
- Includes 11,397 restricted stock units.
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $125.69 to $126.685, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $126.695 to $127.69, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $127.70 to $128.695, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $128.71 to $129.705, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $129.72 to $130.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $130.74 to $130.95, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- 25% of the shares subject to the option vest on the first anniversary measured from March 14, 2016 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2016 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 14, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 27, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Billionaire Hedge Funds
